Moderna Inc.
MRNA | NASDAQ
$194.82
+$12.71 (+6.98%)
At close: Sep 24, 2026, 4:00 PM ET
$178.79
-$3.57 (-1.96%)
Pre-market:
Sep 24, 2026, 9:15 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -4.06 | -4.49 | -8.06 | 8.45 | 8.38 | -53.30 |
PEG Ratio | 0.19 | 0.18 | 0.05 | -0.28 | -0.01 | -2.02 |
PS Ratio | 5.90 | 4.99 | 5.55 | 3.75 | 5.77 | 49.59 |
PB Ratio | 1.33 | 1.46 | 2.74 | 3.70 | 7.24 | 15.56 |
P/FCF Ratio | -5.56 | -3.94 | -9.93 | 15.45 | 7.68 | 20.33 |
P/OCF Ratio | -6.12 | -5.32 | -12.18 | 14.21 | 7.51 | 19.65 |
OCF/S Ratio | -96.35 | -93.90 | -45.53 | 26.39 | 76.79 | 252.30 |
Debt / Equity Ratio | 0.22 | 0.07 | 0.09 | 0.06 | 0.06 | 0.09 |
Quick Ratio | 3.22 | 3.62 | 3.36 | 2.54 | 1.60 | 1.42 |
Current Ratio | 3.29 | 3.67 | 3.42 | 2.73 | 1.76 | 1.43 |
Asset Turnover | 0.16 | 0.23 | 0.37 | 0.73 | 0.72 | 0.11 |
Interest Coverage | -307.40 | -164.38 | -111.55 | 324.83 | 738.67 | -77.19 |
Return on Equity | -32.62% | -32.67% | -34.03% | 43.73% | 86.26% | -29.17% |
Return on Assets | -22.87% | -25.18% | -25.58% | 32.34% | 49.46% | -10.18% |
Return on Invested Capital | -29.70% | -32.53% | -27.46% | 38.93% | 77.53% | -25.63% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 55.35% | 54.24% | 31.47% | 71.31% | 85.24% | 95.12% |
Net Profit Margin | -145.16% | -111.32% | -68.84% | 44.30% | 68.80% | -92.99% |
Pretax Profit Margin | -142.39% | -112.75% | -57.56% | 50.73% | 74.90% | -92.67% |
Operating Profit Margin | -158.13% | -123.32% | -61.90% | 49.91% | 74.97% | -94.99% |
FCF Margin | -106.22% | -126.76% | -55.86% | 24.27% | 75.19% | 243.91% |
EBITDA Margin | -131.33% | -106.10% | -47.94% | 52.73% | 76.31% | -87.55% |
Add to Watchlist
Select watchlists to add or remove MRNA